{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:15:52Z","timestamp":1793740552114,"version":"4.6.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.gtc.2013.01.001","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T15:47:21Z","timestamp":1363189641000},"page":"399-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":204,"title":["Gastrointestinal Stromal Tumors"],"prefix":"10.1016","volume":"42","author":[{"given":"Markku","family":"Miettinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Lasota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2013.01.001_bib1","first-page":"71","article-title":"Ultrastructure of gastric leiomyoma","volume":"87","author":"Welsh","year":"1969","journal-title":"Arch Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/jcp.36.1.57","article-title":"Intermediate filaments in smooth muscle tumors","volume":"36","author":"Evans","year":"1983","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000478-198309000-00001","article-title":"Gastric stromal tumors. Reappraisal of histogenesis","volume":"7","author":"Mazur","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.gtc.2013.01.001_bib5","first-page":"1259","article-title":"Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal","volume":"153","author":"Kindblom","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/cncr.20862","article-title":"Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era \u2013 a population-basede study in western Sweden","volume":"103","author":"Nilsson","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.gtc.2013.01.001_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.21167","article-title":"Gastrointestinal stromal tumors in Iceland, 1990-2003: the Icelandic GIST study, a population-based incidence and pathologic risk stratification study","volume":"117","author":"Tryggvason","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gtc.2013.01.001_bib8","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/PAS.0b013e31806ab2c3","article-title":"\u201cSeedling\u201d mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common in cidental tumors of thevesophagogastric junction","volume":"31","author":"Abraham","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.pas.0000213307.05811.f0","article-title":"Minute sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show KIT mutations","volume":"31","author":"Agaimy","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5858\/2002-126-0481-MSTOTG","article-title":"Malignant stromal tumor of the gallbladder with interstitial cells of Cajal phenotype","volume":"126","author":"Mendoza-Marin","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.gtc.2013.01.001_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3346\/jkms.2004.19.5.763","article-title":"Malignant gastrointestinal stromal tumor of the gallbladder","volume":"1","author":"Park","year":"2004","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.gtc.2013.01.001_bib12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/PAS.0b013e3181937bb3","article-title":"Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma","volume":"3","author":"Al-Daraji","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.pas.0000209847.59670.c8","article-title":"Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: a clinicopathologic study of 8 cases","volume":"30","author":"Herawi","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/373347a0","article-title":"W\/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity","volume":"373","author":"Huizinga","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.gtc.2013.01.001_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0016-5085(99)70560-3","article-title":"Blockade of kit signaling induces transdifferentiation of interstitial cells of Cajal to a smooth muscle phenotype","volume":"117","author":"Torihashi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2013.01.001_bib16","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1007\/s00018-004-4273-y","article-title":"Kit as a human oncogenic tyrosine kinase","volume":"61","author":"Kitamura","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.gtc.2013.01.001_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2006.12.010","article-title":"KIT mutations in GIST","volume":"17","author":"Fletcher","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.gtc.2013.01.001_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2559.2008.02977.x","article-title":"Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumors","volume":"53","author":"Lasota","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.gtc.2013.01.001_bib19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc3143","article-title":"Gastrointestinal stromal tumours: origin and molecular oncology","volume":"1","author":"Corless","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.gtc.2013.01.001_bib20","first-page":"4297","article-title":"Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors","volume":"59","author":"Taniguchi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.gtc.2013.01.001_bib21","first-page":"8118","article-title":"KIT activation is a ubiquitous feature of gastrointestinal stromal tumors","volume":"61","author":"Rubin","year":"2001","journal-title":"Cancer Res"},{"issue":"5 Suppl 17","key":"10.1016\/j.gtc.2013.01.001_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/sonc.2001.29181","article-title":"Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options","volume":"28","author":"Demetri","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0145-2126(01)00028-5","article-title":"Classes of c-KIT activating mutations: proposed mechanisms of action and implications in disease classification and therapy","volume":"25","author":"Longley","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.gtc.2013.01.001_bib24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.11323","article-title":"Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors","volume":"106","author":"Wardelmann","year":"2003","journal-title":"Int J Cancer"},{"issue":"25","key":"10.1016\/j.gtc.2013.01.001_bib25","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1200\/JCO.2005.19.554","article-title":"Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS)","volume":"23","author":"Mart\u00edn","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pas.0000146010.92933.de","article-title":"Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic studies of 1765 cases with long-term follow-up","volume":"29","author":"Miettinen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib27","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/01.MP.0000097365.72526.3E","article-title":"Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course","volume":"16","author":"Lasota","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib28","first-page":"3329","article-title":"Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors","volume":"9","author":"Antonescu","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gtc.2013.01.001_bib29","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0046-8177(03)00407-6","article-title":"KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin","volume":"34","author":"Lasota","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1349-7006.2001.tb01121.x","article-title":"Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese","volume":"92","author":"Sakurai","year":"2001","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.gtc.2013.01.001_bib31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ejca.2006.01.030","article-title":"KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours","volume":"42","author":"Debiec-Rychter","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gtc.2013.01.001_bib32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/CCO.0b013e32833a6b8e","article-title":"Personalized cancer therapy for gastrointestinal stromal tumor: synergizing tumor genotyping with imatinib plasma levels","volume":"22","author":"Marrari","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000478-200604000-00008","article-title":"Gastrointestinal stromal tumors (GISTs) of the jejunum and ileum \u2013 a clinicopathologic, immunohistochemical and molecular genetic study of 906 cases prior to imatinib with long-term follow-up","volume":"31","author":"Miettinen","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9440(10)64946-2","article-title":"KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors","volume":"156","author":"Lux","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/modpathol.2008.2","article-title":"Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study of 54 cases","volume":"21","author":"Lasota","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.gtc.2013.01.001_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/labinvest.3700122","article-title":"A\u00a0great majority of GISTs with PDGFRA mutations represent gastric tumors with low or no malignant potential","volume":"84","author":"Lasota","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.gtc.2013.01.001_bib38","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1200\/JCO.2005.14.068","article-title":"PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in\u00a0vitro sensitivity to imatinib","volume":"23","author":"Corless","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1148\/rg.232025146","article-title":"Gastrointestinal stromal tumors: radiologic features with pathologic correlation","volume":"23","author":"Levy","year":"2003","journal-title":"Radiographics"},{"key":"10.1016\/j.gtc.2013.01.001_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/cncr.20360","article-title":"Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy","volume":"102","author":"Vander Noot","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.gtc.2013.01.001_bib41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00464-010-1522-z","article-title":"Endoscopic ultrasound-guided trucut biopsy of gastrointestinal mesenchymal tumor","volume":"25","author":"DeWitt","year":"2011","journal-title":"Surg Endosc"},{"key":"10.1016\/j.gtc.2013.01.001_bib42","first-page":"728","article-title":"CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34","volume":"11","author":"Sarlomo-Rikala","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1309\/LX9U-F7P0-UWDH-8Y6R","article-title":"Immunohistochemical staining fo KIT (CD117) in soft tissue sarcomas is very limited in distribution","volume":"117","author":"Hornick","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00000478-200407000-00007","article-title":"KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications","volume":"28","author":"Medeiros","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/labinvest.3700360","article-title":"GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology","volume":"86","author":"Lasota","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.gtc.2013.01.001_bib46","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1113\/jphysiol.2009.176198","article-title":"Expression of anoctamin 1\/TMEM16A by interstitial cells of Cajal is fundamental for slow wave activity in gastrointestinal muscles","volume":"587","author":"Hwang","year":"2009","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.gtc.2013.01.001_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-9440(10)63279-8","article-title":"The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status","volume":"165","author":"West","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib48","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/PAS.0b013e3181a90e1a","article-title":"DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases","volume":"33","author":"Miettinen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib49","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1158\/0008-5472.CAN-04-0559","article-title":"Protein kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs)","volume":"64","author":"Duensing","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.gtc.2013.01.001_bib50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1440-1827.2005.01806.x","article-title":"PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors","volume":"55","author":"Motegi","year":"2005","journal-title":"Pathol Int"},{"key":"10.1016\/j.gtc.2013.01.001_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.semdp.2006.09.001","article-title":"Gastrointestinal stromal tumors: pathology and prognosis at different sites","volume":"23","author":"Miettinen","year":"2006","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib52","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1470-2045(09)70242-6","article-title":"Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis","volume":"10","author":"Gold","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib53","first-page":"3899","article-title":"DNA sequence cop number changes in gastrointestinal stromal tumors tumor progression and prognostic significance","volume":"60","author":"El-Rifai","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.gtc.2013.01.001_bib54","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1158\/1078-0432.CCR-11-1610","article-title":"Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors","volume":"18","author":"Lagarde","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gtc.2013.01.001_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jamcollsurg.2012.05.008","article-title":"Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence","volume":"215","author":"McCarter","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.gtc.2013.01.001_bib56","first-page":"645","article-title":"Microscopic margins of resection influence primary gastrointestinal stromal tumor survival","volume":"35","author":"Catena","year":"2012","journal-title":"Onkologie"},{"key":"10.1016\/j.gtc.2013.01.001_bib57","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/01.sla.0000219739.11758.27","article-title":"Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors","volume":"243","author":"Novitsky","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.gtc.2013.01.001_bib58","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.surg.2005.08.011","article-title":"Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60\u00a0operated cases","volume":"139","author":"Otani","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.gtc.2013.01.001_bib59","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1245\/s10434-010-1517-y","article-title":"Laparoscopic varsus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison","volume":"18","author":"Karakousis","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib60","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1007\/s00464-012-2374-5","article-title":"Laparoscopic approaches to gastric gastrointestinal stromal tumors: an institutional review of 57 cases","volume":"26","author":"Pucci","year":"2012","journal-title":"Surg Endosc"},{"key":"10.1016\/j.gtc.2013.01.001_bib61","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.surg.2009.10.035","article-title":"Tailored laparoscopic resection for suspected gastri gastrointestinal stromal tumors","volume":"147","author":"Sasaki","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.gtc.2013.01.001_bib62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1470-2045(09)70017-8","article-title":"Emergency surgery in the era of molecular treatment of solid tumours","volume":"10","author":"Rutkowski","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib63","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejrad.2008.10.009","article-title":"Follow-up of hepatic and peritoneal metastases of gastrointestinal stromal tumors (GIST) under imatinib therapy requires different criteria of radiologic evaluation (size is not everything!!!)","volume":"69","author":"Mabille","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.gtc.2013.01.001_bib64","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","article-title":"Effect of tyrosine kinase inhibitor STI571 in a patient with metastatic gastrointestinal stromal tumor","volume":"344","author":"Joensuu","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2013.01.001_bib65","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1093\/annonc\/mds198","article-title":"Adjuvant therapy in primary GIST: state of the art","volume":"23","author":"Reichardt","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib66","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11864-012-0198-0","article-title":"Adjuvant therapy of gastrointestinal stromal tumors (GIST)","volume":"13","author":"Casali","year":"2012","journal-title":"Curr Treat Options Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2013.01.001_bib67","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2010.0116","article-title":"NCCN task force report: update on the management of patients with gastrointestinal stromal tumors","volume":"8","author":"Demetri","year":"2010","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.gtc.2013.01.001_bib68","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(09)60500-6","article-title":"Adjuvant mesylate after resection of localised, primary gastrointestinal stromal tumor: a randomized, double-bling, placebo-controlled trial","volume":"373","author":"Dematteo","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2013.01.001_bib69","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.2012.347","article-title":"One vs. three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial","volume":"307","author":"Joensuu","year":"2012","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2013.01.001_bib70","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/j.seminoncol.2011.01.018","article-title":"Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors","volume":"38","author":"Demetri","year":"2011","journal-title":"Semin Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib71","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/annonc\/mdq076","article-title":"A\u00a0phase II study of evelolimus (RAD001) in combination with imatinib in in patients with imatinib-resistant gastrointestinal stromal tumors","volume":"21","author":"Shoffski","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib72","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1158\/1535-7163.MCT-11-1046","article-title":"The HSP inhibitor, AT13387, is effective against imatinib-sensitive and resistant gastrointestinal stromal tumor models","volume":"11","author":"Smyth","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.gtc.2013.01.001_bib73","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1158\/0008-5472.CAN-05-2933","article-title":"Flavopiridol targets c-KIT transcription and induces apoptosis in gastrointestinal stromal tumor cells","volume":"66","author":"Sambol","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.gtc.2013.01.001_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/gcc.20720","article-title":"Hereditary gastrointestinal stromal tumors sharing the KIT Exon 17 germline mutation p.Asp820Tyr develop through different cytogenetic progression pathways","volume":"49","author":"Veiga","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.gtc.2013.01.001_bib75","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.1009199108","article-title":"Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations","volume":"108","author":"Janeway","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.gtc.2013.01.001_bib76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2796.2009.02110.x","article-title":"The triad of paragangliomas, gastric stromal tumours, and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications","volume":"266","author":"Stratakis","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.gtc.2013.01.001_bib77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.ejhg.5201904","article-title":"Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD","volume":"16","author":"Pasini","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.gtc.2013.01.001_bib78","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1097\/PAS.0b013e3182260752","article-title":"Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age","volume":"35","author":"Miettinen","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib79","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0b013e3182671178","article-title":"immunohistochemical loss of succinate dehydrogenase subunit a (sdha) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation","volume":"37","author":"Miettinen","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib80","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/PAS.0b013e3181d6150d","article-title":"Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types","volume":"34","author":"Gill","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib81","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/modpathol.2010.185","article-title":"SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors","volume":"24","author":"Gaal","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djr130","article-title":"SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing","volume":"103","author":"Pantaleo","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.gtc.2013.01.001_bib83","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/PAS.0b013e3182671155","article-title":"Loss of SDHA expression identifies SDHA mutations in succinase dehydrogenase-deficient gastrointestinal stromal tumors","volume":"37","author":"Dwight","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/modpathol.2012.153","article-title":"Loss of SDHAS predicts SDHA mutations in gastrointestinal stromal tumors","volume":"26","author":"Wagner","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib85","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.10235","article-title":"Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad","volume":"108","author":"Carney","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.gtc.2013.01.001_bib86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/PAS.0b013e3181c20f4f","article-title":"Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases","volume":"34","author":"Zhang","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib87","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-07-1984","article-title":"Molecular characterization of pediatric gastric gastrointestinal stromal tumors","volume":"14","author":"Agaram","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gtc.2013.01.001_bib88","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/jso.21868","article-title":"Special considerations in pediatric gastrointestinal stromal tumors","volume":"104","author":"Pappo","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.gtc.2013.01.001_bib89","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/01.pas.0000159775.77912.15","article-title":"NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics","volume":"29","author":"Andersson","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib90","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/path.1487","article-title":"Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients","volume":"202","author":"Kinoshita","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib91","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.pas.0000176433.81079.bd","article-title":"Gastrointestinal stromal tumors in patients with neurofibromatosis 1. A clinicopathologic study of 45 patients with long-term follow-up","volume":"30","author":"Miettinen","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib92","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/gcc.20589","article-title":"Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors","volume":"47","author":"Agaram","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.gtc.2013.01.001_bib93","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/jcp.2009.064550","article-title":"V600E BRAF mutations are alternative early molecular events in a subset of KIT\/PDGFRA wild-type gastrointestinal stromal tumours","volume":"62","author":"Agaimy","year":"2009","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib94","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1309\/AJCPPCKGA2QGBJ1R","article-title":"BRAF mutation status in gastrointestinal stromal tumors","volume":"133","author":"Hostein","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.gtc.2013.01.001_bib95","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2011.07.029","article-title":"Spectrum of KIT\/PDGFRA\/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST)","volume":"312","author":"Daniels","year":"2011","journal-title":"Cancer Lett"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855313000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855313000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:29:35Z","timestamp":1760178575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855313000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0889855313000198"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2013.01.001","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal Stromal Tumors","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2013.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}